End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.63 MYR | +6.78% | -.--% | -.--% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 100.3 | 190.6 | 218.5 | 333 | 419.4 | 388.5 |
Enterprise Value (EV) 1 | 99.38 | 194.4 | 220.2 | 328.1 | 414.5 | 390.4 |
P/E ratio | 54.3 x | 84.5 x | 39.8 x | 35.3 x | 84 x | 62.4 x |
Yield | 1.02% | 0.57% | 0.56% | 0.41% | 0.97% | 1.11% |
Capitalization / Revenue | 4.95 x | 8.39 x | 7.71 x | 7.88 x | 10.4 x | 8.69 x |
EV / Revenue | 4.9 x | 8.56 x | 7.77 x | 7.76 x | 10.3 x | 8.74 x |
EV / EBITDA | 27.4 x | 40.2 x | 30.5 x | 23.5 x | 41.6 x | 33.5 x |
EV / FCF | 111 x | 84.1 x | 131 x | 40.6 x | 63.3 x | 66.8 x |
FCF Yield | 0.9% | 1.19% | 0.76% | 2.46% | 1.58% | 1.5% |
Price to Book | 6.32 x | 11.2 x | 9.63 x | 9.7 x | 11.9 x | 10.4 x |
Nbr of stocks (in thousands) | 601,950 | 601,950 | 606,810 | 616,710 | 616,710 | 616,710 |
Reference price 2 | 0.1667 | 0.3167 | 0.3600 | 0.5400 | 0.6800 | 0.6300 |
Announcement Date | 30/04/19 | 14/05/20 | 30/04/21 | 29/04/22 | 28/04/23 | 29/02/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 20.28 | 22.71 | 28.33 | 42.26 | 40.27 | 44.69 |
EBITDA 1 | 3.624 | 4.84 | 7.215 | 13.99 | 9.972 | 11.66 |
EBIT 1 | 2.485 | 3.447 | 5.718 | 11.98 | 7.296 | 8.869 |
Operating Margin | 12.25% | 15.18% | 20.18% | 28.36% | 18.12% | 19.85% |
Earnings before Tax (EBT) 1 | 2.489 | 3.432 | 7.272 | 12.6 | 7.377 | 8.542 |
Net income 1 | 1.822 | 2.256 | 5.477 | 9.438 | 5.016 | 6.248 |
Net margin | 8.98% | 9.93% | 19.33% | 22.33% | 12.45% | 13.98% |
EPS 2 | 0.003068 | 0.003747 | 0.009042 | 0.0153 | 0.008100 | 0.0101 |
Free Cash Flow 1 | 0.8919 | 2.312 | 1.676 | 8.083 | 6.545 | 5.849 |
FCF margin | 4.4% | 10.18% | 5.91% | 19.13% | 16.25% | 13.09% |
FCF Conversion (EBITDA) | 24.61% | 47.77% | 23.22% | 57.78% | 65.63% | 50.14% |
FCF Conversion (Net income) | 48.96% | 102.49% | 30.6% | 85.64% | 130.48% | 93.61% |
Dividend per Share 2 | 0.001700 | 0.001800 | 0.002000 | 0.002200 | 0.006600 | 0.007000 |
Announcement Date | 30/04/19 | 14/05/20 | 30/04/21 | 29/04/22 | 28/04/23 | 29/02/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 3.77 | 1.71 | - | - | 1.9 |
Net Cash position 1 | 0.94 | - | - | 4.9 | 4.85 | - |
Leverage (Debt/EBITDA) | - | 0.7786 x | 0.2376 x | - | - | 0.1632 x |
Free Cash Flow 1 | 0.89 | 2.31 | 1.68 | 8.08 | 6.54 | 5.85 |
ROE (net income / shareholders' equity) | 13.9% | 13.7% | 27.6% | 33.1% | 14.4% | 17.2% |
ROA (Net income/ Total Assets) | 7.8% | 8.24% | 10.6% | 17% | 8.98% | 9.98% |
Assets 1 | 23.35 | 27.38 | 51.8 | 55.58 | 55.85 | 62.6 |
Book Value Per Share 2 | 0.0300 | 0.0300 | 0.0400 | 0.0600 | 0.0600 | 0.0600 |
Cash Flow per Share 2 | 0.0100 | 0.0100 | 0.0100 | 0.0200 | 0.0200 | 0.0200 |
Capex 1 | 2.07 | 1.27 | 4.54 | 4.9 | 4.58 | 3.55 |
Capex / Sales | 10.21% | 5.58% | 16.03% | 11.59% | 11.37% | 7.95% |
Announcement Date | 30/04/19 | 14/05/20 | 30/04/21 | 29/04/22 | 28/04/23 | 29/02/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-.--% | 81.97M | |
-15.68% | 16.57B | |
+4.50% | 12.51B | |
+4.48% | 11.69B | |
+6.18% | 10.36B | |
+26.38% | 8.38B | |
-2.87% | 7.75B | |
+20.39% | 7.12B | |
+3.08% | 6.6B | |
+46.01% | 4.54B |
- Stock Market
- Equities
- MHCARE Stock
- Financials Metro Healthcare